A

Apex Healthcare Bhd
KLSE:AHEALTH

Watchlist Manager
Apex Healthcare Bhd
KLSE:AHEALTH
Watchlist
Price: 2.55 MYR -1.16% Market Closed
Market Cap: 1.8B MYR
Have any thoughts about
Apex Healthcare Bhd?
Write Note

Relative Value

The Relative Value of one AHEALTH stock under the Base Case scenario is 2.48 MYR. Compared to the current market price of 2.55 MYR, Apex Healthcare Bhd is Overvalued by 3%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AHEALTH Relative Value
Base Case
2.48 MYR
Overvaluation 3%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
39
vs Industry
49
Median 3Y
1.9
Median 5Y
1.9
Industry
2.6
Forward
1.8
vs History
39
vs Industry
41
Median 3Y
17.7
Median 5Y
19.8
Industry
23
Forward
19.3
vs History
7
vs Industry
14
Median 3Y
23.6
Median 5Y
22.2
Industry
17.8
vs History
7
vs Industry
8
Median 3Y
45.4
Median 5Y
34.9
Industry
25.4
vs History
85
vs Industry
36
Median 3Y
2.5
Median 5Y
2.6
Industry
2.2
vs History
57
vs Industry
55
Median 3Y
1.6
Median 5Y
1.6
Industry
2.8
Forward
1.5
vs History
63
vs Industry
27
Median 3Y
7.2
Median 5Y
7.4
Industry
5.4
vs History
61
vs Industry
23
Median 3Y
13.8
Median 5Y
14.1
Industry
13.7
Forward
12.2
vs History
71
vs Industry
23
Median 3Y
16.5
Median 5Y
17.1
Industry
17.2
Forward
14.5
vs History
7
vs Industry
17
Median 3Y
20.6
Median 5Y
18.9
Industry
16.5
vs History
7
vs Industry
10
Median 3Y
34.3
Median 5Y
27.9
Industry
19.3
vs History
79
vs Industry
27
Median 3Y
3.1
Median 5Y
3.2
Industry
2

Multiples Across Competitors

AHEALTH Competitors Multiples
Apex Healthcare Bhd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
MY
Apex Healthcare Bhd
KLSE:AHEALTH
1.8B MYR 1.9 20.6 12.9 15.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.5B USD 18.5 90.4 48.6 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
364.1B USD 4.2 24.8 12 15.6
US
Merck & Co Inc
NYSE:MRK
248.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.5B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.5 169.4 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
MY
A
Apex Healthcare Bhd
KLSE:AHEALTH
Average P/E: 31.7
20.6
-73%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.4
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.8
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top